• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.42% Nasdaq Up 0.46%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    34.76 Down 0.13(0.37%) 1:57PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:34.89
    Open:35.13
    Bid:34.76 x 200
    Ask:34.80 x 100
    1y Target Est:44.73
    Beta:1.32
    Next Earnings Date:30-Apr-15ACOR Earnings announcement
    Day's Range:34.62 - 35.44
    52wk Range:28.26 - 45.45
    Volume:156,895
    Avg Vol (3m):741,171
    Market Cap:1.46B
    P/E (ttm):82.76
    EPS (ttm):0.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACORDown 0.37%1.46B
    BIIBDown 0.44%98.79B
    TEVAUp 1.60%54.78B

    Key Statistics

    Forward P/E (1 yr):37.40
    P/S (ttm):3.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.49
    Quarterly EPS Est (Mar-15) :0.11
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):2.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback